(Q33863309)

29 July 2017

title

Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare (English)

1 reference

29 July 2017

main subject

anti-retroviral agent

0 references

Robert S Hogg

6

0 references

Thomas Kerr

series ordinal

3

object named as

Thomas Kerr

1 reference

29 July 2017

8

Evan Wood

1 reference

29 July 2017

7

Julio Montaner

1 reference

29 July 2017

4

Ruth Zhang

1 reference

29 July 2017

5

Silvia Guillemi

1 reference

29 July 2017

Christine Tapp

1

1 reference

29 July 2017

M-J Milloy

series ordinal

2

1 reference

29 July 2017

publication date

6 April 2011

1 reference

29 July 2017

published in

BMC Infectious Diseases

1 reference

29 July 2017

volume

11

1 reference

29 July 2017

page(s)

86

1 reference

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Delayed access to HIV diagnosis and care: Special concerns for the Southern United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Access and utilization of HIV treatment and services among women sex workers in Vancouver's Downtown Eastside.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Gender differences in factors associated with adherence to antiretroviral therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Treatment of antiretroviral-drug-resistant HIV-1 infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Management of psychiatric disorders in patients infected with human immunodeficiency virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Advances in antiretroviral therapy and viral load monitoring

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080305

Barriers to use of free antiretroviral therapy in injection drug users.

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-86

Highly active antiretroviral therapy and survival in HIV-infected injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-86

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-86

Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-86

Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-86

Depressive symptoms decline among persons on HIV protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-86

Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-11-86

Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users

21 January 2018

1 reference

12 December 2020

Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy

1 reference

12 December 2020

Staging for antiretroviral therapy among HIV-infected drug users

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-11-86

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference